Caresyntax - About the company
Caresyntax is a series C company based in San Francisco (United States), founded in 2013. It operates as an AI platform that captures and analyzes operating‑room data to optimize surgical workflows and improve patient outcomes. Caresyntax has raised $291M in funding from investors like PFM Health Sciences, IPF Partners and Surgical. The company has 222 active competitors, including 73 funded and 15 that have exited. Its top competitors include companies like ClearPoint Neuro, LensAR and Onkos Surgical.
Company Details
AI platform that captures and analyzes operating‑room data to optimize surgical workflows and improve patient outcomes. The platform that aggregates and analyzes operating‑room data to provide actionable insights for surgical teams, aiming to streamline workflows and enhance procedural outcomes.
- Website
- caresyntax.com
- Email ID
- *****@caresyntax.com
- Phone Number
- +1 **********
- Registered Address
- Komturstrasse 18 a 12099 Berlin
Key Metrics
Founded Year
2013
Location
San Francisco, United States
Stage
Series C
Total Funding
$291M in 9 rounds
Latest Funding Round
Investors
Ranked
8th among 222 active competitors
Employee Count
126 as on Oct 31, 2026
Investment & Acquisitions
Similar Companies
Legal entities associated with Caresyntax
Caresyntax is associated with 2 legal entities given below:
Legal Entity Name | Date of Incorporation | Revenue | Latest Employee Count | Reports |
|---|---|---|---|---|
CARESYNTAX CORPORATION CIN: 7203324 , United States, Active | Dec 20, 2018 | - | 58 (As on Dec 31, 2024) | - |
caresyntax GmbH CIN: HRB7 , Germany, Active | Apr 22, 1990 | - | - |
Sign up to download Caresyntax's company profile
Caresyntax's funding and investors
Caresyntax has raised a total funding of $291M over 9 rounds. Its first funding round was on Sep 26, 2017. Its latest funding round was a Series C round on Aug 15, 2024 for $*****. 15 investors participated in its latest round. Caresyntax has 29 institutional investors.
Here is the list of recent funding rounds of Caresyntax:
Filter this list
Date of Funding | Funding Amount | Round Name | Post-Money Valuation | Revenue Multiple | Lead Investors | Other Investors |
|---|---|---|---|---|---|---|
Aug 15, 2024 | 1162944 | Series C | 6390165 | 2999307 | 8771717 | 4774738 |
Aug 15, 2024 | 9150861 | Conventional Debt | 7651093 | 3696321 | 7200263 | 9484366 |
Feb 14, 2024 | 6708667 | Series C | 9936247 | 5604775 | 7575249 |
View details of Caresyntax's funding rounds and investors
Caresyntax's founders and board of directors
Founder? Claim ProfileHere are the details of Caresyntax's key team members:
- Matt Krueger: CEO of Caresyntax. Contact Info: 1 email address
Caresyntax's Board of Directors
Caresyntax's board has 1 active member. Timothy Lantz is part of team.Here is the list of Caresyntax's board of directors:
Name | Type | Representing | Status | Duration |
|---|---|---|---|---|
edttrzs | Team | - | Past | 7y 9m |
haqozdd | Team | - | Past | 2y 5m |
lpth{lp | Team | - | Current | 3y 8m |
hmvghov | Independent board member | - | Past | 1y 1m |
{{l{kye | Independent board member | - | Past | 7y 8m |
View details of Caresyntax's Founder profiles and Board Members
Caresyntax's employee count trend
Caresyntax has 126 employees as of Oct 26. Here is Caresyntax's employee count trend over the years:
Access Tracxn on any website
Install Tracxn ExtensionOur Google Chrome extension lets you view company details while browsing their websites
Caresyntax's Competitors and alternates
Top competitors of Caresyntax include ClearPoint Neuro, LensAR and Onkos Surgical. Here is the list of Top 10 competitors of Caresyntax, ranked by Tracxn score:
Get insights and benchmarks for competitors of 2M+ companies! Sign up today!
Rank | Company Details | Short Description | Total Funding | Investors | Tracxn Score |
|---|---|---|---|---|---|
1st | ClearPoint Neuro 1998, Irvine (United States), Public | Developer of MRI-guided stereotactic system for neurological interventions | $33.7M | 64/100 | |
2nd | LensAR 2004, Orlando (United States), Acquired | Laser Technology with AR feature for cataract surgery | $99M | 64/100 | |
3rd | Onkos Surgical 2015, Parsippany Troy Hills (United States), Series C | Modular segmental solutions (3D printing) for orthopedic procedures | $110M | 63/100 | |
4th | Proprio 2016, Seattle (United States), Series B | Manufacturer of surgical navigation platforms using artificial intelligence and sensors | $74.2M | 63/100 | |
5th | Apella 2021, San Francisco (United States), Series B | Developer of surgical systems for the operating room | $101M | 63/100 | |
6th | Hypervision Surgical 2020, London (United Kingdom), Series A | AI-based tissue analysis software for surgical precision | $31M | 60/100 | |
7th | VitVio 2023, San Francisco (United States), Seed | AI and computer vision platform for surgical operating rooms | $10M | 59/100 | |
8th | Caresyntax 2013, San Francisco (United States), Series C | AI platform that captures and analyzes operating‑room data to optimize surgical workflows and improve patient outcomes | $291M | 55/100 | |
9th | MediView 2017, Cleveland (United States), Series A | Developer of augmented reality visualization systems for medical surgical procedures | $117M | 58/100 | |
10th | Sim and Cure 2014, Montpellier (France), Series A | Designs new generations software to improve neurovascular planning process | $15.3M | 55/100 |
Looking for more details on Caresyntax's competitors? Click here to see the top ones
Caresyntax's Investments and acquisitions
Caresyntax has acquired Syus. Caresyntax has not made any investments as of now.Reports related to Caresyntax
Here is the latest report on Caresyntax's sector:
News related to Caresyntax
Media has covered Caresyntax for 1 event in last 1 year, It was about partnerships.
•
Vector Science & Therapeutics and Caresyntax Announce Real-World Evidence PartnershipPR Newswire•Jul 17, 2026•Caresyntax
•
•
Caresyntax and Qaelon Medical announce data intelligence partnership to address devastating impact of surgical leaksPR Newswire•Jan 09, 2025•Caresyntax, Qaelon Medical
•
•
Caresyntax Awarded 2024 German AI Prize for Advancing Surgical IntelligenceBusiness Wire•Sep 27, 2024•Caresyntax
•
Caresyntax brings in $180M for its vendor-neutral precision platformThe Robot Report•Aug 17, 2024•Caresyntax, Symbiotic Capital, MTIP, Bioniq and 18 others
•
surgical.ai Backs Caresyntax in $180M Series C Extension to Accelerate Adoption of AI-enabled SurgeryTMC•Aug 16, 2024•Surgical, Caresyntax, Optum Ventures, Symbiotic Capital and 1 other
•
Caresyntax secures $180M to build AI-powered ‘Android of robotic surgery’Techio•Aug 15, 2024•Caresyntax, Symbiotic Capital, Optum Ventures, BlackRock and 16 others
•
surgical.ai Backs Caresyntax in $180M Series C Extension to Accelerate Adoption of AI-enabled Surgeryintelligence360•Aug 15, 2024•Surgical, Caresyntax, Symbiotic Capital, MTIP and 13 others
•
Avant Technologies Appoints Jared Pelski as VP Business DevelopmentAiThority•Jan 23, 2024•Avant Technology, Caresyntax
Are you a Founder ?
FAQs about Caresyntax
Explore our recently published companies
- Reputyze Asia - Vietnam based, 2018 founded, Unfunded company
- Next Level - Dublin based, 2009 founded, Unfunded company
- ROFIX d.o.o. Slovenija - Grosuplje based, 1888 founded, Unfunded company
- F-Code - Poland based, 2023 founded, Unfunded company
- Argo Steel - Kings Lynn based, 1987 founded, Unfunded company
- The Granddaughter - United States based, Unfunded company